Explore how the FDA’s class II classification of clinical mass spectrometry systems, with special controls, impacts safety, effectiveness, and regulatory compliance. Gain insight into the De Novo process and its role in facilitating market access for innovative medical devices, thereby enhancing patient care by reducing regulatory barriers.
In this course you will learn the following:
* Understand the classification process and criteria for the clinical mass spectrometry system.
* Identify the special controls required for compliance.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.
FDA Class II Classification for Clinical Mass Spectrometry Devices
$9.99
1 year of access
Course Content
FDA Class II Classification for Clinical Mass Spectrometry Devices
